{"id":14519,"date":"2019-05-03T10:30:33","date_gmt":"2019-05-03T08:30:33","guid":{"rendered":"https:\/\/www.satt.fr\/?p=14519"},"modified":"2019-05-03T11:01:44","modified_gmt":"2019-05-03T09:01:44","slug":"satt-up-mai-2019","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/","title":{"rendered":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019"},"content":{"rendered":"<p><strong>Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les SATT. Au programme : Lev\u00e9es de fonds, signature de licences, investissements, r\u00e9compenses&#8230; Depuis leur cr\u00e9ation, les SATT ont contribu\u00e9 \u00e0 la cr\u00e9ation de 370 start-up Deep Tech #SATTUP !<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>La start-up E-attract laur\u00e9ate du 5e appel \u00e0 projet d&#8217;IGNfab gr\u00e2ce \u00e0 son indicateur environnement, biodiversit\u00e9 et attractivit\u00e9. <\/strong><em>(Pulsalys)<\/em><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-14452 size-thumbnail\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/e-attract-accueil-b-retina-150x50.png\" alt=\"\" width=\"150\" height=\"50\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/e-attract-accueil-b-retina-150x50.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/e-attract-accueil-b-retina-300x99.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/e-attract-accueil-b-retina-200x66.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/e-attract-accueil-b-retina.png 427w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/strong><\/p>\n<p>A l\u2019occasion de la 5e \u00e9dition de l\u2019IGNfab portant sur l\u2019innovation \u00e0 partir des donn\u00e9es g\u00e9ographiques, la startup lyonnaise e-attract a \u00e9t\u00e9 distingu\u00e9e, ainsi que 4 autres laur\u00e9ats. Avec sa solution vivrou.com, e-attract am\u00e9liore durablement la vie des citoyens en les aidant dans leurs choix de vie structurants. En tenant compte de l\u2019expression de leurs besoins et de leurs attentes, vivrou.com offre un service int\u00e9gr\u00e9, digital, qui r\u00e9sout les principales contraintes de la mobilit\u00e9 r\u00e9sidentielle en tenant compte des usagers et des acteurs du territoire. Son moteur de matching unique permet d\u2019identifier les lieux de vie id\u00e9aux, de mani\u00e8re personnalis\u00e9e et ind\u00e9pendante.<\/p>\n<p><a href=\"https:\/\/www.e-attract.com\/\">www.e-attract.com<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-14499 size-thumbnail alignright\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/footer_logo-150x52.png\" alt=\"\" width=\"150\" height=\"52\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/footer_logo-150x52.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/footer_logo-200x70.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/footer_logo.png 296w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>La SATT Ouest Valorisation entre au capital de GoLiver Therapeutics.<\/strong>\u00a0<em>(Ouest Valorisation)<\/em><\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\">D\u00e9p\u00f4t de brevets, programme de maturation, transfert technologique, accompagnement \u00e0 la cr\u00e9ation, depuis l\u2019origine, la SATT Ouest Valorisation est associ\u00e9e au d\u00e9veloppement de GoLiver Therapeutics. Au coeur des priorit\u00e9s de l\u2019i-site NExT Sant\u00e9 du Futur, ce premier investissement de la SATT dans le capital d\u2019une start-up des Pays de la Loire confirme son soutien financier \u00e0 une biotech prometteuse.<\/p>\n<p><a href=\"https:\/\/golivertx.com\/\">golivertx.com<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-14501 size-thumbnail alignright\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/edBiHUY3I6nTavGQNKg7UnWAjXe1556628411094_200x200-150x56.png\" alt=\"\" width=\"150\" height=\"56\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/edBiHUY3I6nTavGQNKg7UnWAjXe1556628411094_200x200-150x56.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/edBiHUY3I6nTavGQNKg7UnWAjXe1556628411094_200x200.png 200w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>ALENTIS Therapeutics launches raising CHF 12.5min a Series A to develop novel therapeutics in advanced liver disease and cancer.<\/strong>\u00a0<em>(Conectus)<\/em><\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\">ALENTIS Therapeutics (\u201cALENTIS\u201d), a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer, announced today the completion of a Series A financing of CHF 12.5million (Euro 11.1m; USD 12.5m). The Swiss venture capital firms BioMedPartners and BB Pureos Bioventures co-led the round and were joined by BPI France, Schroder Adveq and the German High-Tech Gr\u00fcnderfonds (HTGF).<\/p>\n<p><a href=\"https:\/\/alentis.ch\/\">alentis.ch<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-14503 size-thumbnail alignright\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/new_logo_microlight-150x17.png\" alt=\"\" width=\"150\" height=\"17\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/new_logo_microlight-150x17.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/new_logo_microlight-300x34.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/new_logo_microlight-768x86.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/new_logo_microlight-1024x115.png 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/new_logo_microlight-500x56.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/new_logo_microlight-600x67.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/new_logo_microlight-200x22.png 200w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>Microlight3D acquiert la soci\u00e9t\u00e9 Smart Force Technologies et ajoute la 2D \u00e0 ses syst\u00e8mes de micro-impression 3D.<\/strong>\u00a0<em>(Linksium)<\/em><\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\">Microlight3D, qui d\u00e9veloppe des machines de microimpression 3D ultra-haute r\u00e9solution pour applications industrielles et scientifiques, annonce aujourd\u2019hui l\u2019acquisition de Smart Force Technologies (SFT), un fabricant fran\u00e7ais, plusieurs fois prim\u00e9, d\u2019un syst\u00e8me de lithographie sans masque pour micro-impression 2D. SFT est une spin-off du Laboratoire des Technologies de la Micro\u00e9lectronique (LTM), un centre de recherche de premier plan sp\u00e9cialis\u00e9 dans la miniaturisation de dispositifs micro- et nano\u00e9lectroniques, affili\u00e9 au CNRS, \u00e0 l\u2019Universit\u00e9 Grenoble Alpes et au CEA.<\/p>\n<p><a href=\"http:\/\/www.microlight.fr\/\">www.microlight.fr<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-14505 size-thumbnail alignright\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/ZQ-150x33.png\" alt=\"\" width=\"150\" height=\"33\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/ZQ-150x33.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/ZQ-300x65.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/ZQ-500x109.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/ZQ-600x131.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/ZQ-200x44.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/ZQ.png 740w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>Zymoptiq : Une nouvelle technologie de mesure enzymatique pour r\u00e9pondre aux nouveaux enjeux de l\u2019enzymologie.<\/strong>\u00a0<em>(SATT Nord)<\/em><\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\">La SATT Nord et la soci\u00e9t\u00e9 Zymoptiq ont sign\u00e9 une licence exclusive pour l\u2019exploitation de la technologie Reflex d\u00e9velopp\u00e9e au sein de l\u2019Institut d&#8217;\u00e9lectronique de micro\u00e9lectronique et de nanotechnologie (IEMN) de Lille.\u00a0La soci\u00e9t\u00e9 ZYMOPTIQ laur\u00e9ate du prix I-lab 2018 (concours national d\u2019aide \u00e0 la cr\u00e9ation d\u2019entreprises de technologies innovantes) propose donc un dispositif cl\u00e9s en main de mesure et dosage enzymatique.\u00a0Ce dispositif ouvre de larges perspectives en mati\u00e8re d\u2019ing\u00e9nierie enzymatique pour les activit\u00e9s de criblage, de contr\u00f4le qualit\u00e9, d\u2019am\u00e9lioration de process et de formulation de mix enzymatique pour lesquels les m\u00e9thodes existantes sont tr\u00e8s limit\u00e9es.<\/p>\n<p><a href=\"https:\/\/sattnord.fr\/nouvelle-technologie-de-mesure-enzymatique-repondre-aux-nouveaux-enjeux-de-lenzymologie\/\">sattnord.fr\/zymoptiq<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-14509 size-thumbnail alignright\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/logo-slider-99x150.png\" alt=\"\" width=\"99\" height=\"150\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/logo-slider-99x150.png 99w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/logo-slider-198x300.png 198w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/logo-slider-300x456.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/logo-slider-66x100.png 66w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/logo-slider.png 428w\" sizes=\"auto, (max-width: 99px) 100vw, 99px\" \/>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\"><strong>Neurallys l\u00e8ve 750 000 euros pour d\u00e9velopper la neurochirurgie connect\u00e9e.<\/strong>\u00a0<em>(IDF Innov)<\/em><\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\">Neurallys annonce aujourd\u2019hui avoir achev\u00e9 une lev\u00e9e de fonds de 750 000 euros aupr\u00e8s du groupe Doliam et de HACFutur, pour acc\u00e9l\u00e9rer le d\u00e9veloppement de son implant connect\u00e9, au service de milliers de patients souffrant d\u2019hydroc\u00e9phalie.\u00a0Neurallys a cr\u00e9\u00e9 une solution unique : un \u00ab barom\u00e8tre \u00bb permettant de mesurer et d\u2019enregistrer la pression intracr\u00e2nienne en continu.\u00a0Gr\u00e2ce \u00e0 ce capteur mini-invasif implant\u00e9 devant la valve dont les patients sont d\u00e9j\u00e0 tous porteurs pour faire face \u00e0 la maladie, il sera enfin possible de r\u00e9unir de pr\u00e9cieuses informations pour aider au diagnostic et au suivi, limiter les hospitalisations &amp; interventions inutiles et pr\u00e9venir les dysfonctions de mat\u00e9riel, qui peuvent avoir de lourdes cons\u00e9quences.<\/p>\n<p><a href=\"http:\/\/neurallys.com\/home\/\">neurallys.com<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-14511 size-thumbnail alignright\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/telechargement-1-150x28.png\" alt=\"\" width=\"150\" height=\"28\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/telechargement-1-150x28.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/telechargement-1-300x55.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/telechargement-1-500x92.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/telechargement-1-200x37.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/telechargement-1.png 522w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>SKILDER, un outil pens\u00e9 pour optimiser le processus de recrutement sur la base de \u201ccomp\u00e9tences comportementales\u201d (Soft Skills) au travers de jeux et simulations on-line.<\/strong>\u00a0<em>(Pulsalys)<\/em><\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\">R\u00e9volu le temps o\u00f9 l&#8217;on pouvait tout miser sur le dipl\u00f4me ? De nouvelles comp\u00e9tences p\u00e8sent d\u00e9sormais lourd dans le choix final du candidat lors d&#8217;un recrutement : les softs skills, ou comp\u00e9tences comportementales. Un certain &#8220;savoir \u00eatre&#8221; du candidat qui s\u00e9duit de plus en plus les recruteurs. C&#8217;est sur ce volet de la s\u00e9lection qu&#8217;intervient SKILDER, une plateforme de simulation d&#8217;interactions professionnelles, v\u00e9ritable d\u00e9nicheur de talents.<\/p>\n<p><a href=\"http:\/\/www.skilder.fr\/\">www.skilder.fr<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-14507 size-thumbnail alignright\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/dynacure_logo-150x40.png\" alt=\"\" width=\"150\" height=\"40\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/dynacure_logo-150x40.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/dynacure_logo-300x80.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/dynacure_logo-200x53.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/dynacure_logo.png 488w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>Dynacure Announces Approval of Clinical Trial Application for DYN101, an Antisense Medicine to Treat Rare Disease \u2018Centronuclear Myopathies.<\/strong>\u00a0<em>(Conectus)<\/em><\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\">Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Clinical Trial Application (CTA) for DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 (DNM2) for the treatment of Centronuclear Myopathies (CNM). Dynacure expects to initiate its first in human study, a Phase 1 \/ 2 study \u2018Unite-CNM\u2019, in the second half of 2019. DYN101 is being developed in collaboration with Ionis Pharmaceuticals [NASDAQ: IONS], the leader in RNA-targeted drug discovery.<\/p>\n<p><a href=\"https:\/\/www.dynacure.com\/\">www.dynacure.com<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-14495 size-thumbnail alignright\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/cropped-Logo-NHT512350-150x93.png\" alt=\"\" width=\"150\" height=\"93\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/cropped-Logo-NHT512350-150x93.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/cropped-Logo-NHT512350-300x185.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/cropped-Logo-NHT512350-162x100.png 162w, https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/05\/cropped-Logo-NHT512350.png 442w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>NH TherAguix annonce une lev\u00e9e de fonds de 13 millions d\u2019euros, men\u00e9e par Bpifrance.<\/strong>\u00a0<em>(Pulsalys)<\/em><\/p>\n<p class=\"_3vFF3xH4Yd\" dir=\"ltr\" data-test=\"textbox\">NH TherAguix annonce la cl\u00f4ture d\u2019un tour de table de 13 millions d\u2019euros, men\u00e9 par Bpifrance, via le fonds InnoBio 2 qui r\u00e9alise son premier investissement, aux c\u00f4t\u00e9s de Supernova Invest, investisseur historique, et Omnes, Arbevel, nouveaux entrants. NH TherAguix produit et d\u00e9veloppe son m\u00e9dicament candidat AGuIX, dans le traitement des cancers solides, dont le potentiel permettrait d\u2019augmenter la survie des patients canc\u00e9reux ainsi que leur qualit\u00e9 de vie lorsqu\u2018il est combin\u00e9 \u00e0 la radioth\u00e9rapie.<\/p>\n<p><a href=\"http:\/\/nhtheraguix.com\/\">nhtheraguix.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les SATT. Au programme : Lev\u00e9es de fonds, signature de licences, investissements, r\u00e9compenses&#8230; Depuis leur cr\u00e9ation, les SATT ont contribu\u00e9 \u00e0 la cr\u00e9ation de 370 start-up Deep Tech #SATTUP ! &nbsp; La start-up E-attract laur\u00e9ate du 5e appel \u00e0 projet d&#8217;IGNfab gr\u00e2ce \u00e0 son indicateur environnement, biodiversit\u00e9 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":11835,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[562],"tags":[],"class_list":["post-14519","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-satt-network"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019\",\"datePublished\":\"2019-05-03T08:30:33+00:00\",\"dateModified\":\"2019-05-03T09:01:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/\"},\"wordCount\":1073,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png\",\"articleSection\":[\"SATT Network\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/\",\"url\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/\",\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png\",\"datePublished\":\"2019-05-03T08:30:33+00:00\",\"dateModified\":\"2019-05-03T09:01:44+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png\",\"width\":6399,\"height\":3569},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/","twitter_misc":{"Written by":"admin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019","datePublished":"2019-05-03T08:30:33+00:00","dateModified":"2019-05-03T09:01:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/"},"wordCount":1073,"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","articleSection":["SATT Network"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/","url":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/","name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","datePublished":"2019-05-03T08:30:33+00:00","dateModified":"2019-05-03T09:01:44+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","width":6399,"height":3569},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/satt-up-mai-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #7 \u2013 Mai 2019"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/14519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=14519"}],"version-history":[{"count":1,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/14519\/revisions"}],"predecessor-version":[{"id":14522,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/14519\/revisions\/14522"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/11835"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=14519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=14519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=14519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}